Ikena Oncology
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Ikena Oncology generated cash of -$79,743,000, which is less than the previous year. Cash used in financing activities reached the amount of $75,980,000 last year. Net change in cash is therefore $60,381,000.
Cash Flow
| 2019 | 47.92M | -316K | 16.31M |
|---|---|---|---|
| 2020 | -37.82M | 2.92M | 116.18M |
| 2021 | -60.25M | -1.76M | 131.73M |
| 2022 | -74.10M | -99.28M | 1.09M |
| 2023 | -79.74M | 64.14M | 75.98M |
IKNA Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 60.79M | 233.08M | 163.36M | 82.08M | 18.15M |
Operating activities | |||||
Net income | -68.16M | -68.76M | -34.11M | -44.25M | -16.81M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.02M | 751K | 544K | 300K | 243K |
Stock-based compensation expense | 7.63M | 7.52M | 5.17M | 1.79M | 1.16M |
| Deferred income tax benefit | 7.63M | 7.52M | 5.17M | 1.79M | 1.16M |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | -291K | 361K | 519K | -1.33M |
Inventories | 0 | 0 | -361K | -519K | 1.33M |
Accounts payable | -2.87M | -291K | 361K | 519K | -1.33M |
Cash generated by operating activities | -79.74M | -74.10M | -60.25M | -37.82M | 47.92M |
Investing activities | |||||
Purchases Of Investments | -90.05M | -216.33M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -414K | -1.43M | -1.76M | -766K | -316K |
Acquisitions Net | 40.03M | 97.85M | 0 | 3.68M | 0 |
Cash generated by investing activities | 64.14M | -99.28M | -1.76M | 2.92M | -316K |
Financing activities | |||||
Common Stock Issued | 37.42M | 1.09M | 131.30M | 116.18M | 16.31M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -663K | 0 | -146K | -57K | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 75.98M | 1.09M | 131.73M | 116.18M | 16.31M |
Net Change In Cash | 60.38M | -172.29M | 69.72M | 81.28M | 63.92M |
Cash at end of period | 121.17M | 60.79M | 233.08M | 163.36M | 82.08M |
| Data source | Data source | Data source |